Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01062685Completed

Near Infrared Spectroscopy (St02)

Role: collaborator

NCT03113721Unknown

Assessment of Heparin Binding Protein for the Prediction of Severe Sepsis

Role: lead

NCT02424721Terminated

Sepsis Assessment in Belgian Emergency Rooms

Role: lead

NCT03629795Completed

Serum Sample Collection to Determine Analytical Performance Characteristics of the ADVIA Centaur PAPPA and BhCG Assays

Role: lead

NCT01392508Completed

IMproved PREdiction of Severe Sepsis in the Emergency Department

Role: lead

All 5 trials loaded